The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert
Panel identified and reviewed the available evidence for the ten most important areas of …

Metastatic Prostate Cancer Interventions added to androgen-deprivation therapy in men with
metastatic prostate cancer have recently been noted to increase survival. Decisions about …

… Based on decarbonized electricity and electrolysis (ie oxygen is directly separated from iron
ore by adding electrons to Fe 2 O 3 ), iron ore is either solved or suspended in a solid state …

Background Radium-223 dichloride (radium-223), an alpha emitter, selectively targets bone
metastases with alpha particles. We assessed the efficacy and safety of radium-223 as …

PURPOSE: Prostate-specific antigen (PSA) is a glycoprotein that is found almost exclusively
in normal and neoplastic prostate cells. For patients with metastatic disease, changes in …

Background Metastatic castration-resistant prostate cancer remains fatal despite recent
advances. Prostate-specific membrane antigen (PSMA) is highly expressed in metastatic …

Rituximab improves outcomes for persons with lymphoproliferative disorders and is
increasingly used to treat immune-mediated illnesses. Recent reports describe 2 patients with …

Background In advanced prostate cancer (APC), successful drug development as well as
advances in imaging and molecular characterisation have resulted in multiple areas where …

Background Multiple loss-of-function alterations in genes that are involved in DNA repair,
including homologous recombination repair, are associated with response to poly(adenosine …

Background Innovations in treatments, imaging, and molecular characterisation in advanced
prostate cancer have improved outcomes, but there are still many aspects of management …